对非家族性高胆固醇血症和混合性高脂血症的雷卡西马布单疗法:第3期REMAIN-1随机试验
Mingtong Xu1, Zhen Wang2, Yumin Zhang3
1Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Journal of the American College of Cardiology
|October 10, 2024
概括
雷卡西马布有效降低高胆固醇血症患者的LDL-C,提供灵活的剂量,每12周一次,与安慰剂相似的安全性. 这种长效单克隆抗体为控制胆固醇水平提供了新的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 针对蛋白转化酶亚素/素9型 (PCSK9) 的单克隆抗体有效降低低密度脂蛋白胆固醇 (LDL-C).
- 目前的PCSK9抑制剂通常需要频繁 (每两周或每月一次) 的使用.
- 雷卡西马布是一种新型,长效的人性化单克隆抗体,旨在用于不频繁的剂量.
研究的目的:
- 评估雷卡西马布单独治疗非家族性高胆固醇血症和混合性高脂血症患者的疗效和安全性.
- 评估患有低至中度动脉样硬化心血管疾病 (ASCVD) 风险的患者.
- 探索雷卡西马布的各种剂量策略,以提供灵活的注射选择.
主要方法:
- 一项随机,双盲,安慰剂控制的第三期研究,涉及703名中国患者.
- 患者接受皮下雷卡西马布 (150毫克Q4W,300毫克Q8W或450毫克Q12W) 或安慰剂,以及降脂饮食.
- 主要终点:根据剂量组,12周或16周LDL-C与基线的百分比变化.
主要成果:
- 与安慰剂相比,雷卡西马布在所有测试剂量中显著降低了LDL-C (45.0%52.8%的减少).
- 雷卡西马布的安全性概况与安慰剂相当.
- 与治疗相关的不良事件很少发生,注射部位反应是最常见的 (24周后4.9%).
结论:
- 在低至中度ASCVD风险的高胆固醇血症患者中,雷卡西马布单疗法显示显著降低了LDL-C.
- 药物耐受性很好,安全性与安慰剂相当,即使每隔12周一次的剂量间隔也不频繁.
- 雷卡西马布为胆固醇管理提供了一个有前途的,长效的治疗选择.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
579
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
579
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3


